148 related articles for article (PubMed ID: 18032873)
1. Diphenylcyclopropenone immunotherapy in ophiasis.
Singh G; Okade R; Naik C; Dayanand CD
Indian J Dermatol Venereol Leprol; 2007; 73(6):432-3. PubMed ID: 18032873
[No Abstract] [Full Text] [Related]
2. Treatment of alopecia areata with diphenylcyclopropenone.
van der Steen PH; van Baar HM; Perret CM; Happle R
J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):253-7. PubMed ID: 2007671
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone.
van der Steen PH; van Baar HM; Happle R; Boezeman JB; Perret CM
J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):227-30. PubMed ID: 2007667
[TBL] [Abstract][Full Text] [Related]
4. Age dependence of diphenylcyclopropenone sensitization in patients with alopecia areata.
Temesvári E; González R; Marschalkó M; Horváth A
Contact Dermatitis; 2004 Jun; 50(6):381-2. PubMed ID: 15274737
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata: topical immunotherapy--application and practical problems.
MacDonald N; Wiseman MC; Shapiro J
J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S36-40. PubMed ID: 11776938
[No Abstract] [Full Text] [Related]
6. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
[TBL] [Abstract][Full Text] [Related]
7. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico.
Herz-Ruelas ME; Lozano-Peña AK; Ocampo-Candiani J; Gómez-Flores M; Welsh-Lozano O; Vázquez-Martínez O
Australas J Dermatol; 2020 Feb; 61(1):e137-e139. PubMed ID: 31385296
[No Abstract] [Full Text] [Related]
9. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
10. Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients.
Nasimi M; Abedini R; Ghandi N; Seirafi H; Mehdizade MS; Tootoonchi N
Dermatol Ther; 2020 Nov; 33(6):e13808. PubMed ID: 32530566
[No Abstract] [Full Text] [Related]
11. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
12. Urticaria after topical immunotherapy with diphenylcyclopropenone.
Francomano M; Seidenari S
Contact Dermatitis; 2002 Nov; 47(5):310-1. PubMed ID: 12534538
[No Abstract] [Full Text] [Related]
13. Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
Bröcker EB; John SM; Steinhausen D; Hamm H
Arch Dermatol Res; 1991; 283(2):133-4. PubMed ID: 2069412
[No Abstract] [Full Text] [Related]
14. Topical immunotherapy with diphencyprone in Indians with alopecia areata.
Sharma VK; Muralidhar S
Clin Exp Dermatol; 1998 Nov; 23(6):291-2. PubMed ID: 10233630
[No Abstract] [Full Text] [Related]
15. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
Ohlmeier MC; Traupe H; Luger TA; Böhm M
J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
[TBL] [Abstract][Full Text] [Related]
16. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of alopecia areata with diphenylcyclopropenone].
Kietzmann H; Hardung H; Christophers E
Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata in children: treatment with diphencyprone.
Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
[TBL] [Abstract][Full Text] [Related]
19. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
Wasyłyszyn T; Borowska K
Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
[TBL] [Abstract][Full Text] [Related]
20. Bald spots on a young girl.
Usatine RP
J Fam Pract; 2004 Jan; 53(1):33-6. PubMed ID: 14709264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
